Opportunity Information: Apply for PAR 09 044
Apply for PAR 09 044
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Pre Application for the 2009 NIDA Avant Garde Award Program for HIV/AIDS Research (X02)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Dec 12, 2008 and posted on Dec 12, 2008.
- Applicants must submit their applications by Feb 27, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education State governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Pre-Application for the 2009 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) (Funding Opportunity Number PAR-09-044) is a National Institutes of Health (NIH) funding opportunity issued by the National Institute on Drug Abuse (NIDA) to identify exceptionally creative scientists with bold, high-impact ideas related to HIV/AIDS in the context of drug abuse. The central aim is to complement NIDA's standard investigator-initiated grant programs by encouraging unusually innovative projects that could open up entirely new directions for preventing and treating HIV/AIDS among people who use drugs. In practice, the program is looking for proposals that may not fit well within traditional grant mechanisms because they are especially unconventional, exploratory, or transformative, but still grounded in strong scientific rationale and potential for major public health impact.
This particular announcement is for an X02 pre-application stage, meaning it functions as a screening and selection step rather than a direct funding mechanism. Applications submitted under PAR-09-044 are reviewed by external reviewers, and the goal of that review is to identify the most outstanding concepts and investigators. Only the strongest pre-applications are expected to move forward. Investigators whose submissions are judged to be top-tier are then invited to submit a full application under a separate funding announcement, RFA-DA-09-011. A key detail is that no awards are made under PAR-09-044 itself; all actual grant awards, if made, are made only through the subsequent RFA-DA-09-011 process. In other words, PAR-09-044 is a competitive gateway to the full Avant Garde Award competition, not the award mechanism.
From an administrative standpoint, the opportunity is categorized as discretionary funding, using the grant funding instrument, and it falls under the broad activity area of education and health. The CFDA listing associated with it is 93.279 (Drug Abuse and Addiction Research Programs). There is no cost sharing or matching requirement, which means applicants are not required to commit non-federal matching funds as a condition of eligibility or award (though actual budget rules would be addressed in the full application stage under the RFA).
Eligibility is intentionally broad, reflecting an effort to attract the strongest ideas wherever they are found. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, state governments, federally recognized and other tribal governments and tribal organizations, non-profit organizations both with and without 501(c)(3) status (excluding higher education institutions where specified), for-profit organizations other than small businesses, and small businesses. The announcement also explicitly includes a variety of special categories such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. The overall message is that institutional type is not meant to be a limiting factor as long as the applicant can carry out the proposed research and meets NIH requirements.
The key timeline details show the announcement was posted and created on December 12, 2008, with an original and current closing date of February 27, 2009, and an archive date of March 30, 2009. The full announcement is available via the NIH Grants Guide webpage listed in the additional information link, and NIDA also pointed applicants to a dedicated FAQ document for program-specific guidance. For technical access issues, NIH provided contact support through the NIH Office of Extramural Research (OER) webmaster email.
Overall, PAR-09-044 is best understood as an elite, innovation-focused pre-application solicitation designed to surface and select unusually promising HIV/AIDS research concepts tied to drug abuse. It rewards originality and potential impact at the selection stage by offering an invitation to apply for full funding under RFA-DA-09-011, while making clear that the pre-application itself does not result in an award.
FAQs: Pre-Application for the 2009 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) - PAR-09-044
What is PAR-09-044?
PAR-09-044 is a National Institutes of Health (NIH) funding opportunity issued by the National Institute on Drug Abuse (NIDA) for a pre-application stage (X02) under the 2009 NIDA Avant Garde Award Program for HIV/AIDS Research. It is designed to identify exceptionally creative scientists with bold, high-impact HIV/AIDS research ideas in the context of drug abuse.
What is the main purpose of this opportunity?
The purpose is to complement NIDA's standard investigator-initiated grant programs by encouraging unusually innovative, unconventional, or transformative research concepts that could open new directions for preventing and treating HIV/AIDS among people who use drugs.
Is this a grant that provides funding if selected?
No. PAR-09-044 is an X02 pre-application screening and selection step. No awards are made under PAR-09-044 itself. Any actual grant awards, if made, occur only through the subsequent full application process under a separate funding announcement, RFA-DA-09-011.
If no awards are made, why submit a pre-application?
The pre-application functions as a competitive gateway into the Avant Garde Award competition. External reviewers assess pre-applications to identify the most outstanding concepts and investigators. Only top-tier submissions are expected to be invited to submit a full application under RFA-DA-09-011.
What happens after the pre-application review?
Pre-applications are reviewed by external reviewers to identify the strongest concepts and investigators. Investigators with the most outstanding pre-applications may be invited to submit a full application under RFA-DA-09-011.
What types of projects is NIDA trying to encourage through this program?
NIDA is seeking unusually innovative projects that may not fit well within traditional grant mechanisms because they are especially unconventional, exploratory, or transformative, but still grounded in strong scientific rationale and with potential for major public health impact related to HIV/AIDS and drug abuse.
What research focus is emphasized in the announcement?
The focus is HIV/AIDS research in the context of drug abuse, specifically ideas that could substantially advance prevention and treatment of HIV/AIDS among people who use drugs.
Who is the intended audience for this opportunity?
The announcement is intended to attract exceptionally creative scientists and investigators with bold, high-impact ideas. It is positioned as an elite, innovation-focused solicitation rather than a standard mechanism for routine research proposals.
What is the funding opportunity number?
The Funding Opportunity Number is PAR-09-044.
What does "X02" mean in this context?
X02 refers to a pre-application stage. In this announcement, it means the submission is used for screening and selection and is not itself an award mechanism.
What institute is sponsoring this opportunity?
The opportunity is issued by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH).
What is the next step if invited to continue?
If selected as top-tier at the pre-application stage, investigators are invited to submit a full application under the separate funding announcement RFA-DA-09-011. Grant awards, if any, would be made through that later process.
What type of funding is this categorized as?
Administratively, it is categorized as discretionary funding using the grant funding instrument.
What is the broad activity area for this opportunity?
The activity area is listed broadly under education and health.
What CFDA program is associated with this opportunity?
The CFDA listing associated with the opportunity is 93.279 (Drug Abuse and Addiction Research Programs).
Is there a cost sharing or matching requirement?
No. The announcement states there is no cost sharing or matching requirement for PAR-09-044.
Who is eligible to apply?
Eligibility is broad and includes: public and state-controlled institutions of higher education; private institutions of higher education; state governments; federally recognized tribal governments and other tribal governments; tribal organizations; non-profit organizations with and without 501(c)(3) status (excluding higher education institutions where specified); for-profit organizations other than small businesses; and small businesses.
Are any specific institution types explicitly included?
Yes. The announcement explicitly includes Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
Does institutional type affect eligibility?
The announcement emphasizes that institutional type is not meant to be a limiting factor, as long as the applicant can carry out the proposed research and meets NIH requirements.
When was PAR-09-044 posted?
The announcement was posted (and created) on December 12, 2008.
What was the application closing date?
The original and current closing date listed for the announcement is February 27, 2009.
When was the opportunity archived?
The archive date is March 30, 2009.
Where can applicants find the full announcement?
The full announcement is available via the NIH Grants Guide webpage referenced in the additional information link described in the opportunity summary.
Was there any additional guidance mentioned for applicants?
Yes. NIDA pointed applicants to a dedicated FAQ document for program-specific guidance.
Who should be contacted for technical access issues?
For technical access issues, NIH provided contact support through the NIH Office of Extramural Research (OER) webmaster email.
How should applicants think about PAR-09-044 in the overall competition?
PAR-09-044 should be viewed as an elite, innovation-focused pre-application solicitation intended to surface unusually promising HIV/AIDS research concepts tied to drug abuse. It does not make awards itself, but it can lead to an invitation to apply for full funding under RFA-DA-09-011.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Wenatchee Subbasin Anadromous Fishery Habitat Improvement
Previous opportunity: Mentored Patient Oriented Research Career Development Award (K23)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 09 044
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 09 044) also looked into and applied for these:
| Funding Opportunity |
|---|
| Innovative and Applied Emerging Technologies in Biospecimen Science (R21) Apply for RFA CA 09 004 Funding Number: RFA CA 09 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Innovative and Applied Emerging Technologies in Biospecimen Science (R33) Apply for RFA CA 09 005 Funding Number: RFA CA 09 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Application and Use of Transformative Emerging Technologies in Cancer Research (R21) Apply for RFA CA 09 006 Funding Number: RFA CA 09 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Application and Use of Transformative Emerging Technologies in Cancer Research (R33) Apply for RFA CA 09 007 Funding Number: RFA CA 09 007 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative Technology Development for Cancer Research (R21) Apply for RFA CA 09 008 Funding Number: RFA CA 09 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) Apply for PAR 09 050 Funding Number: PAR 09 050 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Patient Oriented Research Career Development Award to Promote Diversity (K23) Apply for PAR 09 051 Funding Number: PAR 09 051 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Apply for PAR 09 052 Funding Number: PAR 09 052 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanism for Time Sensitive Research Opportunities (R03) Apply for PAR 06 249 Funding Number: PAR 06 249 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Support Opportunity for Addiction Research (SOAR) for New Investigators (R03) Apply for RFA DA 09 021 Funding Number: RFA DA 09 021 Agency: National Institutes of Health Category: Education Health Funding Amount: $25,000 |
| Midcareer Investigator Award in Mouse Pathobiology Research (K26) Apply for PAR 09 053 Funding Number: PAR 09 053 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools for Germplasm Cryopreservation (STTR) R41/R42 Apply for PA 09 054 Funding Number: PA 09 054 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools for Germplasm Cryopreservation (SBIR) R43/R44 Apply for PA 09 055 Funding Number: PA 09 055 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pre application for a Biomedical Technology Research Resource (X02) Apply for PAR 08 260 Funding Number: PAR 08 260 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIH Supported Centers for Population Health and Health Disparities (CPHHD) (P50) Apply for RFA CA 09 001 Funding Number: RFA CA 09 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Informatics Training for Global Health (ITGH) (D43) Apply for RFA TW 09 001 Funding Number: RFA TW 09 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $230,000 |
| Comprehensive Minority Institution/Cancer Center Partnership (Limited Competition U54) Apply for RFA CA 09 501 Funding Number: RFA CA 09 501 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Prevention Research Small Grant Program (R03) Apply for PAR 08 055 Funding Number: PAR 08 055 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Genome Characterization Centers and Genome Data Analysis Centers for The Cancer Genome Atlas Research Network (TCGA)U24 Apply for RFA CA 09 010 Funding Number: RFA CA 09 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Imaging Science Track Award for Research Transition (I/START) R03 Apply for PAR 09 073 Funding Number: PAR 09 073 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 09 044", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.